There were 57 reports of possible allergic reactions in the perioperative period in the first 2000 incidents reported to the Australian Incident Monitoring Study. These were examined and classified with respect to presentation, clinical course, agents implicated and management strategies employed. Reactions were graded as to probability of allergic aetiology and severity of systemic disturbance. 1Wo deaths were reported. A method of determining an "allergy score" was devised as an indication of which reactions may be most deserving of further investigation.
The term "anaphylaxis", in medical use for over ninety years, is today confined to a specific syndrome with a well defined aetiology, mechanism and clinical response spectrum. I This classical clinical picture is, however, found to be the exception rather than the rule when one comes to examine first-hand reports of possible allergy associated with anaesthesia and surgery.
To anaesthetists it represents only a part of the constellation of allergic responses, which are themselves an even smaller part of the broad clinical picture of adverse drug reactions. Allergic phenomena, ranging from localised to widespread, from trivial to severe systemic physiological insult and death within minutes, are often difficult to identify from this broad clinical picture, 2 and diagnosis may be delayed or missed. Anaphylaxis and anaphylactoid responses are themselves clinically indistinguishable, (hence the term "clinical anaphylaxis") and have been confused with non-allergic conditions such as vasovagal episode, drug overdose and carcinoid syndrome. I Correct clinical diagnosis is vital for early optimal management of life-threatening responses regardless of aetiology or mechanism. Retrospective determination of pathophysiology and causative agent(s) is also essential for follow-up of mild or severe reactions to define what drugs must be avoided (and what drugs are safe) with future anaesthetics. 2, 3 Severe allergic responses are less well managed in crisis simulations than other events,4 and this seems to be related to problems with making a clinical diagnosis. It appears that if the possibility of allergy is not considered early in the course of an incident, it is more likely to be missed altogether, and inappropriate or sub-optimal management persisted with; this phenomenon of "mindset" or "confirmation bias" is discussed elsewhere in this symposium. 5 It is worth exploring the available data for confirmation of this impression, and for any aids to the early diagnosis of allergic reactions, however mediated. Emphasis has necessarily been on the clinical details, since few of the reports examined in this study included any results of investigation for allergy.
Various attempts have been made to estimate the frequency of anaphylaxis in anaesthetic practice 2
and a generally accepted range of 1 in 6000 to 1 in 20,000 anaesthetics has been quoted. However it may be that, for all potentially severe allergic responses, the figure is significantly higher. The difficulties in recognition of possible allergic phenomena associated with anaesthesia include the following.
1. Anaesthesia and surgery themselves may modify symptoms and signs of allergy. 9 2. Multiplicity of drugs and other agents given within a short time frame makes it difficult to reconstruct the relationship of anyone agent to a response.
3. Bronchospasm and hypotension, especially when they do not occur together, are usually due to commoner causes. 4. Even severe reactions are often symptomatically well managed by anaesthetists, leading to low morbidity. 5. In the absence of a clear clinical syndrome of allergy, and with good response to treatment, longterm follow up and investigation are at best haphazard.
The purpose of this analysis is to identify which of the first 2000 incidents reported to the Australian Incident Monitoring Study (AIMS) are most likely to represent true allergic phenomena, and to examine and classify them with respect to presentation, clinical course, and management strategies.
METHODS
AIMS involves the voluntary, anonymous reporting of any unintended incident which reduced, or could have reduced, the safety margin for the patient. AIMS methods have been described elsewhere in this symposium. 10 The first 2000 incidents reported to AIMS were analysed for possible allergy-related phenomena, resulting in the extraction of 176 reports for detailed examination. These were then sorted with respect to the occurrence of various indicators of allergic response. Although the structured part of the AIMS reporting form contains standardised information, the amount and type of detail provided by reporters in the narrative section was variable, at least to the degree commonly seen in the non-directed provision of clinical history. The severity of the clinical reaction was graded I-Ill, based on the degree of physiological insult, the time course and response to treatment as described in the reports. This particular classification of severity is proposed for allergic responses associated with anaesthesia, as previous classifications of severity have been agent-specific, not confined to the perioperative period, or refer to conscious subjects. 11 1< The final choice of indicators and their relative weighting (called "significance index"), was determined from examination of the literature, 1.'.1001 and is shown in Table 1 . On this basis the 176 incidents were each given an "allergy score" by first mUltiplying the major indices, and then adding the minor indices: in this manner any two of the first four indices (hypotension, cutaneous signs, bronchospasm and severity grade Ill) score 4, any three score 8, and an incident manifesting all four would score 16, with each minor significance index raising the allergy score by one extra point. The incidents with the highest scores were taken to be those most likely to be true allergic phenomena (see Table 2 ). Further examination of the data was confined to those incidents with a score of 3 or more, i.e. those considered suggestive, probable, or highly likely. This included extracting and collating information about the severity of the clinical reaction, possible causative agents, drugs used in the management of the signs and symptoms, and the type of "follow-up", including whether any further testing was done and what information was given to the patient.
RESULTS
There were 57 incidents, all involving patients over 14 years of age, with allergy scores of 3 or greater ( Table  2 ). This represents just under 3070 of the first 2000 incidents. The 19 incidents which scored 8 or more on this scale (probable to very likely allergic responses) represent nearly 1070 of the first 2000 incidents. Only 12 incidents were classified as "full anaphylaxis" in the paper in this symposium on the role of monitors in patients undergoing general anaesthesia (see S03 and S03a in Table 4 , p. 589). Many allergic reactions in this study were first detected as hypotension (there were 71 incidents which first presented as hypotension with vasodilation) or as bronchospasm (24 incidents) and these were therefore classified under these headings in this paper. The grade of severity for the 57 incidents is shown in Table 3 . The suspected or possible causative agents are listed by class in Table 4 . Drugs used in the management of the 57 incidents are listed in Table 5 . The types of "follow-up" or further management as described in the reports are summarised in Table 6 . " Includes 2 protamine/heparin reactions, one of whom (ASA 3 risk) died on the second postoperative day.
DISCUSSION
Of these 57 incidents, 40 (70070) were associated with two or more of the first three indicators listed in Table  I , and 17 patients (30070) suffered a grade III reaction. This would suggest that, if anyone of the signs hypotension, bronchospasm, or skin manifestation (including airway oedema) is noticed, especially if severe, the possibility of allergy must be considered early, and the presence of other signs and symptoms ( awake at the time of the reaction, 10 (71070) had one or more of the minor indicators «g) and (h) in Table  I ) as the initial manifestation.
There was a history of previous drug allergy in 18070 of the 57 incidents, compared with a reported frequency of 29070 in other studies and 13.5070 in the general surgical population. IS Its value as a predictor of allergy is unclear. 16 Examinations of the distribution of allergy scores of 3 or greater, as shown in Table 2 , reveals three separate groups of incidents ( Figure I) : the largest group (38 incidents) clustering around an allergy score of 4 or 5, the next group (14 incidents) with a peak around an allergy score of 9, and a third small (5 incidents), but quite distinct group with allergy scores around 17. One would need to apply the allergy scoring system to a much larger group of patients, in whom the results of investigations for allergy were subsequently known, to determine if such aphasic distribution is reproducible and is of clinical relevance.
Two thirds of the 57 reactions occurred in association with the induction of anaesthesia (Table 4 ); this includes all instances in which suxamethonium was given and also in which the drugs used to induce anaesthesia were not stated. Agents from more than one class of drug may be implicated in the same reaction if several drugs are given within a short time, as commonly happens in anaesthesia.
The commoner drug management strategies employed in the acute situation are listed in Table 5 . Intravenous fluids, oxygen, leg elevation and general supportive measures were used early and appropriately in nearly all cases, and are only separately listed in Table 5 for those incidents where no other treatment was given. Adrenaline was given in this period in 38 instances (67070), and in 28 of these, it was the drug of first choice. Dosages, where stated, range from 15 micrograms to 7 milligrams, all in adult patients. The most common dose was approximately I milligram in two or more divided doses, often given subcutaneously in the first instance, then intravenously if the reaction progressed. There are many kinds of tests to establish the occurrence of an allergic response, and to determine its pathophysiology and its causative event(s), both in the acute phase and later on ("delayed testing"). ,.1"-.,,,-However, there is still "no single in vivo or in vitro test which will provide all the answers". 24 Although recent studies S.'-suggest accuracy may be approaching 90070 in the population of patients referred to an allergy clinic after a suspected episode of clinical anaphylaxis, this is a different population from that examined in these AIMS reports. A rational approach to the investigation of incidents which deviate from the more easily recognised severe "classical anaphylaxis" response is desirable. Table 6 shows the types of follow-up management mentioned in the reports. There are four groups. I. Incidents in which some form of allergy testing was arranged. 2. Incidents in which the patient either died before allergy testing, or in which some further measure other than formal testing was employed. ego communication to patient, medical or hospital staff of a possible drug reaction. 3. Patients who were admitted to an intensive care unit for observation or further management, and who did not fall into either of the foregoing categories. Presumably a proportion of these would subsequently undergo formal allergy testing, but there is no way of telling from this series of AIMS reports how large this proportion might be, or what information (if any) was provided to the patient after the event. 4. Patients whose further management or follow up beyond the acute phase is simply not stated in the incident report. A total of 15 incidents were further investigated with allergy tests, of which 6 proved positive and 1 negative (intradermal testing); 8 results were unknown at the time of reporting.
There were 36 incidents in which investigation of, or communication regarding possible allergic reaction is not mentioned in the report. Of these 36 incidents, 10 had allergy scores of 8 or greater, and 10 had reactions of grade III severity, with an overlap of 5 patients represented in both the above groups.
It is not possible in the type of study represented by AIMS, when looking at a problem as complex as the diagnosis of clinical anaphylaxis, to draw any firm conclusions based on the available data. The absence of a definite end point on which to base quantitative analysis is a problematical, but central point. Allergy clinics and specialist units evaluate a pre-selected population of patients, in the majority of cases well after the incident. With a likely increasing use of acute phase investigations, it may be worth looking at what influences this selection process at the time of the incident, to allow anaesthetists to make more rational, consistent and cost effective decisions in this regard.
The two most noteworthy features to emerge from these reports are: I. The difficulty in making the diagnosis in the acute phase, especially when there is no obvious cutaneous mani festation. 2. The fact that, despite generally good management and the efficacy of adrenaline, follow-up of such incidents is poorly addressed. Perhaps the use of a tool such as the "allergy score" described here may make it easier to quickly decide which incidents are most deserving of both acute phase AnaeSlhesia and Inlensive Care, Vol. 21, No. 5, Oerober, 1993 and delayed testing, with the goal of minimising future avoidable morbidity; the former is easily overlooked in the stress of the incident.
It is hoped that this examination of the first 2000 incidents with respect to allergic phenomena may heighten awareness of this possibility amongst the anaesthetic community, and focus colleagues' attention on the diagnosis and management of allergy in their own practice.
